Biobank

Advancing precision medicine

Biobank

A Biobank is an organized structure that collects, processes, stores, and makes available human biological samples (such as blood, tissue, and DNA). These samples are linked to clinical data and are used for scientific research purposes. Biobanks operate under ethical and legal standards to ensure donor protection and sample quality.

Our Biobank Collections

Donnors

Samples

Sample Type

Description

Research Area Collections

1. select a research area to view its collections

Details

2. select a collection to view its details

–

Donors

–

Samples

–

Sample Type

–

Description

“The GIMM Biobank services allow us to store biological samples in appropriate conditions, reduced cost, in order to maximize its use and scientific productivity in the future (…)”

Professor JP da Silva, University of Coimbra

[sp_wpcarousel id=”376″]

What is a Biobank?

Mission

The mission of the GIMM Biobank is to establish itself as a leading infrastructure for the collection, processing, storage, and sharing of human biological samples. Its goal is to support scientific research and foster advances in translational and personalized medicine. This mission is driven by principles of quality, ethics, and interdisciplinary collaboration.

Impact

The GIMM Biobank has a significant impact in scientific, medical, social, and technological domains. It contributes to scientific advancement, fosters a culture of ethical and collaborative research, and promotes innovation in translational medicine.

History

The GIMM Biobank builds upon the legacy of the iMM Biobank, an initiative of the Lisbon Academic Medical Center (comprising the Santa Maria Local Health Unit, the Faculty of Medicine of the University of Lisbon, and the Instituto de Medicina Molecular João Lobo Antunes – iMM).

The Biobank excelled in fostering scientific collaborations, making its samples available for innovative projects, and driving advances in translational medicine.
The transition to the GIMM Biobank marks a pivotal step in expanding the impact and reaffirming the commitment to excellence in biomedical research.

“We like to be able to match the sample to very high quality and comprehensive clinical and medical information regarding each subject. The GIMM Biobank has allowed us to do that through their clinical collaborators.”

Jon Marks-Bluth, Alchemab Therapeutics